eye cancer

Foghorn sinks plans for eye tumor drug after glimpsing phase 1 data
Fierce Biotech
Wed, 06/28/23 - 10:30 am
Foghorn Therapeutics
FHD-286
eye cancer
clinical trials
Aldeyra Therapeutics reports that FDA rejects eye cancer drug
Benzinga
Wed, 06/21/23 - 10:56 pm
Aldeyra Therapeutics
FDA
eye cancer
ADX-2191
Siren emerges from stealth with plans to marry gene therapy to cancer immunotherapy
BioPharma Dive
Wed, 05/17/23 - 11:21 am
Siren Biotechnology
gene therapy
cancer immunotherapy
brain cancer
eye cancer
Elisabet de los Pinos and her team fuel up for a late-stage quest to deliver a safe eye cancer drug
Endpoints
Mon, 03/22/21 - 09:58 pm
Aura Biosciences
eye cancer
clinical trials
AU-011
Laser-activated eye cancer drug developer Aura Biosciences scores $40M in Medicxi-led round
Endpoints
Tue, 04/2/19 - 12:05 pm
Aura Biosciences
HPV
eye cancer
Medicxi
Celgene’s Alkeran Extends Life in Eye-Cancer Patients in Study
Bloomberg
Sat, 09/24/11 - 12:45 pm
eye cancer
Celgene
Alkeran
melphalan